The United Laboratories International Holdings Limited

HK$7.96As of Sun 8 Nov 2026, 12:00 UTC
HKEX:3933Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 9.59%
Div yield 3.76%
ROE 3.23%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.28
PE TTM 25.08
TSR TTM (34.71%)
Mkt cap HK$15.67B
ROIC 4.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.57
7.76%
(79.74%)
Hold 3|6|1|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.22
0.21
0.23
0.24
23.67%
9.60%
12.90%
6.15%
Revenue¥M
718.8
753.3
779.8
780.5
8.36%
12.90%
11.08%
7.49%
Peers (US$1.999B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.159
0.039
0.038
EBIT/Intx
2.204
0.437
0.432
Own earn%
(8.24)
(149.84)
(142.40)
Sh yield%
30.04
25.18
27.60
Owners
Insiders/Inst%
13.83
78.13
Short interest%
3.49
SBC / revenue%
2.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
8–15
$1 testx
—
Incr. ROIC%
13